A Systematic Review and Meta-Analysis of Randomized Controlled Trials in Use of GLP-1 Receptor Agonist in Type 1 Diabetes Mellitus

被引：0
|
作者：
Panta, Raju
Kunwar, Sumit
Batra, Manav
Ghimire, Dipesh K. C.
Mudgal, Mayuri
Makdissi, Antoine
Chaudhuri, Ajay
Dandona, Paresh
机构：
来源：
DIABETES | 2017年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1156-P
引用
收藏
页码：A308 / A308
页数：1
相关论文
共 50 条
  • [1] Safety and efficacy of GLP-1 and glucagon receptor dual agonist for the treatment of type 2 diabetes and obesity: a systematic review and meta-analysis of randomized controlled trials
    Deng, Bixin
    Ruan, Tiechao
    Lu, Wenting
    Ying, Junjie
    Li, Shiping
    Zhou, Ruixi
    Mu, Dezhi
    [J]. ENDOCRINE, 2024, 86 (01) : 15 - 27
  • [2] GLP-1 Receptor Agonists and Risk of Adverse Cerebrovascular Outcomes in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
    Banerjee, Mainak
    Pal, Rimesh
    Mukhopadhyay, Satinath
    Nair, Kirthana
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2023, 108 (07): : 1806 - 1812
  • [3] GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials
    Chuqing Cao
    Shuting Yang
    Zhiguang Zhou
    [J]. Endocrine, 2019, 66 : 157 - 165
  • [4] GLP-1 receptor agonists and risk of cancer in type 2 diabetes: an updated meta-analysis of randomized controlled trials
    Cao, Chuqing
    Yang, Shuting
    Zhou, Zhiguang
    [J]. ENDOCRINE, 2019, 66 (02) : 157 - 165
  • [5] Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
    Karagiannis, Thomas
    Avgerinos, Ioannis
    Liakos, Aris
    Del Prato, Stefano
    Matthews, David R.
    Tsapas, Apostolos
    Bekiari, Eleni
    [J]. DIABETOLOGIA, 2022, 65 (08) : 1251 - 1261
  • [6] Management of type 2 diabetes with the dual GIP/GLP-1 receptor agonist tirzepatide: a systematic review and meta-analysis
    Thomas Karagiannis
    Ioannis Avgerinos
    Aris Liakos
    Stefano Del Prato
    David R. Matthews
    Apostolos Tsapas
    Eleni Bekiari
    [J]. Diabetologia, 2022, 65 : 1251 - 1261
  • [7] Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Qian Zhou
    Xingxing Lei
    Shunlian Fu
    Pan Liu
    Cong Long
    Yanmei Wang
    Zinan Li
    Qian Xie
    Qiu Chen
    [J]. Diabetology & Metabolic Syndrome, 15
  • [8] Efficacy and safety of tirzepatide, dual GLP-1/GIP receptor agonists, in the management of type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials
    Zhou, Qian
    Lei, Xingxing
    Fu, Shunlian
    Liu, Pan
    Long, Cong
    Wang, Yanmei
    Li, Zinan
    Xie, Qian
    Chen, Qiu
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2023, 15 (01):
  • [9] Use of GLP-1 Receptor Agonists and Occurrence of Thyroid Disorders: a Meta-Analysis of Randomized Controlled Trials
    Hu, Weiting
    Song, Rui
    Cheng, Rui
    Liu, Caihong
    Guo, Rui
    Tang, Wei
    Zhang, Jie
    Zhao, Qian
    Li, Xing
    Liu, Jing
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2022, 13
  • [10] Clinical Outcomes with GLP-1 Receptor Agonists in Patients with Heart Failure: A Systematic Review and Meta-analysis of Randomized Controlled Trials
    Huilei Zhao
    Yang Liu
    Menglu Liu
    Yi Xu
    Qin Ling
    Weichun Lin
    Jing Zhang
    Zhiwei Yan
    Jianyong Ma
    Weiguang Li
    Yujie Zhao
    Peng Yu
    Xiao Liu
    Jingfeng Wang
    [J]. Drugs, 2023, 83 : 1293 - 1307
12345